MPE interviews experts about different aspects of the CARAMBA clinical trialMyeloma, Videos10 April 2023
Listen the voice of myeloma patients in documentary “My myeloma: ready for the steps ahead”Myeloma22 March 2023
ASH 2022 | Myeloma and AL amyloidosis updatesAL amyloidosis, Conferences, Myeloma, Videos12 December 2022
The European Medicines Agency (EMA) approves Melflufen (Pepaxti®) for the treatment of refractory myelomaAccess, Myeloma30 August 2022
EMA recommends conditional marketing authorisation in Europe for teclistamab for relapsed and refractory myelomaAccess, Myeloma28 July 2022
Myeloma Patients Europe (MPE) relaunches Myeloma Access Atlas platformAccess, MPE, Myeloma19 October 2021
